Free Trial

Sempra (SRE) Stock Forecast & Price Target

Sempra logo
$87.96 +0.92 (+1.06%)
(As of 12/24/2024 05:19 PM ET)

Sempra - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
10

Based on 10 Wall Street analysts who have issued ratings for Sempra in the last 12 months, the stock has a consensus rating of "Buy." Out of the 10 analysts, 10 have given a buy rating for SRE.

Consensus Price Target

$91.60
4.14% Upside
According to the 10 analysts' twelve-month price targets for Sempra, the average price target is $91.60. The highest price target for SRE is $99.00, while the lowest price target for SRE is $79.00. The average price target represents a forecasted upside of 4.14% from the current price of $87.96.
Get the Latest News and Ratings for SRE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Sempra and its competitors.

Sign Up

SRE Analyst Ratings Over Time

TypeCurrent Forecast
12/26/23 to 12/25/24
1 Month Ago
11/26/23 to 11/25/24
3 Months Ago
9/27/23 to 9/26/24
1 Year Ago
12/26/22 to 12/26/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
10 Buy rating(s)
10 Buy rating(s)
7 Buy rating(s)
Hold
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$91.60$89.00$85.42$81.65
Forecasted Upside4.14% Upside-6.07% Downside4.28% Upside9.66% Upside
Consensus Rating
Buy
Moderate Buy
Moderate Buy
Moderate Buy

SRE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SRE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sempra Stock vs. The Competition

TypeSempraUtilities CompaniesS&P 500
Consensus Rating Score
3.00
2.53
2.51
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside4.14% Upside29.08% Upside13.49% Upside
News Sentiment Rating
Positive News

See Recent SRE News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/13/2024Morgan Stanley
3 of 5 stars
 UpgradeEqual Weight ➝ Overweight$85.00 ➝ $98.00+11.45%
12/2/2024Barclays
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$89.00 ➝ $99.00+7.05%
11/7/2024Wells Fargo & Company
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$87.00 ➝ $96.00+8.65%
11/7/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$84.00 ➝ $88.00-0.29%
10/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$98.00+14.01%
10/21/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$93.00 ➝ $96.00+12.56%
9/12/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$94.00+15.78%
5/29/2024LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$81.50 ➝ $79.00+4.79%
5/17/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$79.00 ➝ $86.00+10.72%
3/6/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$82.00+15.79%
12/12/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$78.00 ➝ $86.00+16.34%
10/9/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$86.00 ➝ $76.00+12.29%
10/4/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$95.00 ➝ $89.00+34.20%
6/23/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
6/7/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$89.00+20.10%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 08:12 PM ET.


Should I Buy Sempra Stock? SRE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, December 18, 2024. Please send any questions or comments about these Sempra pros and cons to contact@marketbeat.com.

Sempra
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Sempra:

  • Sempra's stock is currently trading at $89.29, reflecting a positive market sentiment and potential for growth.
  • The company has a strong market capitalization of approximately $56.56 billion, indicating stability and investor confidence.
  • Recent analyst upgrades have increased price targets, with Barclays raising their target to $99.00, suggesting strong future performance.
  • Sempra has a solid dividend yield of 2.78%, providing investors with a reliable income stream through quarterly dividends.
  • Institutional investors hold 89.65% of Sempra's stock, which often indicates a strong endorsement of the company's long-term prospects.

Sempra
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Sempra for these reasons:

  • The company reported a quarterly earnings miss, with EPS of $0.89 compared to the consensus estimate of $1.05, raising concerns about profitability.
  • Revenue for the latest quarter was down 16.7% year-over-year, indicating potential challenges in maintaining sales growth.
  • One analyst has issued a sell rating on Sempra, suggesting that there may be underlying issues that could affect stock performance.
  • The company's net margin of 22.63% is solid, but lower than some competitors, which could impact its competitive edge.
  • With a debt-to-equity ratio of 0.89, Sempra has a moderate level of debt, which could pose risks in a rising interest rate environment.

SRE Forecast - Frequently Asked Questions

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Sempra is $91.60, with a high forecast of $99.00 and a low forecast of $79.00.

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sempra in the last twelve months. There are currently 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SRE shares.

According to analysts, Sempra's stock has a predicted upside of 4.14% based on their 12-month stock forecasts.

Over the previous 90 days, Sempra's stock had 1 upgrade by analysts.

Sempra has been rated by research analysts at Barclays, BMO Capital Markets, Evercore ISI, Jefferies Financial Group, Morgan Stanley, and Wells Fargo & Company in the past 90 days.

Analysts like Sempra more than other "utilities" companies. The consensus rating for Sempra is Buy while the average consensus rating for "utilities" companies is Moderate Buy. Learn more on how SRE compares to other companies.


This page (NYSE:SRE) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners